Navigation Links
Mild Sadness Provokes Depressive Thinking in Some Recovered Patients

Some individuals with a history of depression may sink back into thinking patterns associated with the condition when faced with mild stresses or sadness//, increasing their risk for relapse.

Many patients who recover from depression eventually relapse, according to background information in the article. Management of depression usually focuses on alleviating symptoms rather than reducing the risk for recurrence or identifying patients who might relapse after successful treatment. Previous studies have found that some patients who have recovered from depression still show cognitive processes—patterns in thinking, learning and memory—commonly associated with the condition, while others in remission do not. Such cognitive processes include certain ways of explaining events or particular assumptions about self-worth.

Zindel V. Segal, Ph.D., University of Toronto and Centre for Addiction and Mental Health, Ontario, and colleagues randomly assigned 301 patients with major depressive disorder to receive either antidepressant medications or cognitive behavioral therapy (a kind of psychotherapy designed to modify the cognitive processes that are typically associated with depression). Ninety-nine of those whose depression went into remission participated in a second phase of the trial. These 99 participants rated their current mood on a visual scale from sad to happy and underwent an assessment of their dysfunctional attitudes, signs of the cognitive processes that are associated with depression. The researchers then provoked a sad mood by asking participants to listen to a piece of music and try to recall a time in their lives when they felt sad. After this exercise, the participants rated their mood and underwent the dysfunctional attitude assessment a second time and were observed bimonthly for the next 18 months.

Seventy-eight patients completed the full 18 months of follow-up; 47.5 percent of those who had recovered through antidepres sant medication use and 39 percent of those who received cognitive behavioral therapy relapsed during that time period. Regardless of the type of treatment, those who had greater cognitive reactivity—that is, they displayed significantly more dysfunctional beliefs after the sad mood provocation than before it—were more likely to relapse during the 18-month follow-up. This association held true even when researchers considered the number of past episodes of depression each patient had experienced, previously the best known way to predict relapse. In addition, those who took antidepressants were more likely to have greater cognitive reactivity than those in the cognitive behavioral therapy group.

“Our study indicates that even a mild negative mood, when experienced by someone with a history of depression, can reinstate some of the cognitive features observed in depression itself,” the authors write. “The presence of such reactivity in recovered patients signals a residual but heightened risk for episode relapse that has not been fully addressed by treatment.”

Future depression management approaches might aim to help prevent relapse by teaching patients to reflect on the factors that influence their thinking, the authors suggest. “Such treatments may include components that first help patients deliberately monitor and observe their thinking patterns when they feel sad, and then help patients respond to these thoughts and feelings in a way that allows them to inhibit the cognitive elaboration of their content,” they write.

(Source: Nwswise)
'"/>




Related medicine news :

1. Depressive Mothers Do Not Play Enough With Their Infants
2. Sertraline Can Prevent Recurrent Depressive Episodes In Diabetics
3. Inculcating Positive Thoughts Could Eliminate Depressive Mood
4. Positive Thinking
5. Thinking Could Be Affected Due To Hormone Therapy
6. Amnesia Halts Future Thinking: Study
7. Uric Acid Levels Tied to Impaired Thinking in the Elderly
8. Positive Thinking Helps to Ward Off Depression
9. British man Recovered from HIV
10. More Bones of Aborted Fetuses Recovered from Hospital Premises
11. One in Three Heart Attack Patients Have No Chest Pains
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... June 23, 2017 , ... ... Conference from Sept. 18 to 20. , The two-day conference is focused on ... the goal of improving patients’ lives and eliminating racial breast cancer-related disparities. The ...
(Date:6/23/2017)... ... , ... Ross Insurance Agency ( http://www.rossinsuranceagency.com ) saves clients ... (FEMA) recent update of flood zones, more people than ever are in flood ... to reflect the actual risk in flood zone areas during a time when ...
(Date:6/23/2017)... ... June 23, 2017 , ... Jusino Insurance Services, ... communities in the greater Chicago metropolitan area, is embarking on a charity drive ... in Chicago. , Founded in 1897, Hephzibah Children’s Association is one of the ...
(Date:6/22/2017)... FL (PRWEB) , ... June 22, 2017 , ... Branches, ... received more than $245,000 in grant funding to support its programs focused on providing ... Branches, Inc. was awarded a grant by the Foundation of $15,000 to support its ...
(Date:6/22/2017)... ... June 22, 2017 , ... Children’s National Health System ... (AHA) to launch a Rheumatic Heart Disease Center, with the goal of developing ... heart disease (RHD) in high-risk, financially disadvantaged countries and low-income communities across the ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... The Bio Supply Management Alliance (BSMA) has ... and the Biomedical Manufacturing Network to advance ... California by providing a platform for ... workforce development. The primary focus of this alliance is ... well as small and mid-sized biomedical companies. ...
(Date:6/13/2017)... , June 13, 2017 Zimmer Biomet Holdings, ... healthcare, today announced that the U.S. Food and Drug Administration ... June 3, 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning ... manufacturing facility is a measure of the progress we ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company ... from three Phase 3 studies of galcanezumab, an investigational ... including late-breaking data on several key secondary endpoints for ... results from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will ... annual scientific meeting in Boston . ...
Breaking Medicine Technology: